Market closed

MediciNova/MNOV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About MediciNova

MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.

Ticker

MNOV
Trading on

Industry

Biotechnology

Employees

13

MediciNova Metrics

BasicAdvanced
$97M
Market cap
-
P/E ratio
-$0.17
EPS
0.72
Beta
-
Dividend rate
$97M
0.72
$2.16
$1.12
68K
18.243
17.775
0.527
0.858
-9.51%
-13.32%
97.116
1.69
2.26
-11.354
-35.49%
-37.00%
-11.49%

What the Analysts think about MediciNova

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for MediciNova stock.

MediciNova Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

MediciNova Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy MNOV

$

Sign up or log in to buy
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for MediciNova stock?

MediciNova (MNOV) has a market cap of $97M as of October 06, 2024.

What is the P/E ratio for MediciNova stock?

The price to earnings (P/E) ratio for MediciNova (MNOV) stock is 0 as of October 06, 2024.

Does MediciNova stock pay dividends?

No, MediciNova (MNOV) stock does not pay dividends to its shareholders as of October 06, 2024.

When is the next MediciNova dividend payment date?

MediciNova (MNOV) stock does not pay dividends to its shareholders.

What is the beta indicator for MediciNova?

MediciNova (MNOV) has a beta rating of 0.72. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.